Founded in 1947, in 2022 AIBS celebrates its 75th anniversary

"What news from the sea?"

The fish replied: "I have a lot to say, but my mouth is full of water." - Armenian proverb

The San Diego, California shoreline. Credit: Frank McKenna

A small semi-transparent triangle for visual interest
Science Marches On

News & Events

Explore the most recent news about AIBS's initiatives, programs, resources, and events.

Bullet policy, statements · Apr 22, 2022

AIBS Joins Stakeholder Letter on Pathogen Research in Innovation Bills

As Congress proceeds with conference negotiations to reconcile the America COMPETES Act (H.R. 4521) and the U.S. Innovation and Competition Act (S. 1260), a group of scientific and academic organizations, including AIBS, have written to lawmakers urging removal of legislative provisions that would restrict, pause, or alter federally funded research projects that focus on gain of function research of concern or specific pathogens.

In their letter, the groups note that such provisions are overly prescriptive and interfere with the National Science Advisory Board for Biosecurity’s (NSABB) evaluation of and forthcoming recommendations on enhanced potential pandemic pathogen research and dual use research of concern.

“Through collaboration with NSABB, Congress can strike an appropriate balance between safeguarding national security and public health through biosafety and biosecurity measures, while also recognizing the global impact of potential pandemic pathogens, the value and lifesaving potential of research in this area, and the need to study these microbes to address current and future threats,” the letter argues. “Doing otherwise could have serious, negative unintended consequences for potentially lifesaving research.”

Stay current on the latest science policy news. Subscribe to our bi-weekly AIBS Public Policy Report.